Gemzar, Gemcitabine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

96 API Suppliers, 31 USDMF, 27 CEP/COS, 13 JDMF, 9 EU WC, 29 KDMF, 18 NDC API, 44 Listed Suppliers

DEVELOPMENTS

450 Drugs in Development

450 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

336 FDF Dossiers, 92 FDA Orange Book, 172 Europe, 2 Canada, 4 Australia, 24 South Africa, 42 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 1200MG BASE/120ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1300MG BASE/130ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1400MG BASE/140ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1500MG BASE/150ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1600MG BASE/160ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1700MG BASE/170ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1800MG BASE/180ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1900MG BASE/190ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2000MG BASE/200ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2200MG BASE/220ML (EQ 10MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 1 Kirsch Pharma, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 Actylis, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 7 Disintegrants & Superdisintegrants, 6 Parenteral, 3 Co-Processed Excipients, 3 Granulation, 2 API Stability Enhancers, 1 Thickeners and Stabilizers, 1 Solubilizers

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 138 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 24 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

18 APIs, 9 FDF Dossiers, 2 Intermediates

PATENTS & EXCLUSIVITIES

14 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

Xls

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4Pfizer Australia Pty Ltd

filter Active Ingredients Reset all filters

filter Brand Name Reset all filters

01

Pfizer Australia Pty Ltd

Canada

Stanford Drug Discovery Symposium

Not Confirmed

02

Pfizer Australia Pty Ltd

Canada

BPI Europe

Not Confirmed

03

Pfizer Australia Pty Ltd

Canada

BPI Europe

Not Confirmed

04

Pfizer Australia Pty Ltd

Canada

BPI Europe

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Gemzar, Gemcitabine Hydrochloride

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

96 API Suppliers

31 USDMF

27 CEP/COS

13 JDMF

9 EU WC

29 KDMF

18 NDC API

44 Listed Suppliers

DEVELOPMENTS

450 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

336 FDF Dossiers

92 FDA Orange Book

172 Europe

2 Canada

4 Australia

24 South Africa

42 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 1200MG BASE/120ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1300MG BASE/130ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1400MG BASE/140ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1500MG BASE/150ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1600MG BASE/160ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1700MG BASE/170ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1800MG BASE/180ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1900MG BASE/190ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 2000MG BASE/200ML (EQ 10MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 2200MG BASE/220ML (EQ 10MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

13 SPI Pharma

1 Gangwal Healthcare

1 Pfanstiehl

1 Kirsch Pharma

2 Dr. Paul Lohmann GmbH & Co. KGaA

1 Actylis

1 BASF

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

12 Chewable & Orodispersible Aids

10 Direct Compression

10 Taste Masking

7 Disintegrants & Superdisintegrants

6 Parenteral

3 Co-Processed Excipients

3 Granulation

2 API Stability Enhancers

1 Thickeners and Stabilizers

1 Solubilizers

DIGITAL CONTENT

3 Data Compilation #PharmaFlow

1 Stock Recap #PipelineProspector

138 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions

24 Regulatory FDF Prices

2 Annual Reports

MARKET PLACE

18 APIs

9 FDF Dossiers

2 Intermediates

PATENTS & EXCLUSIVITIES

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 200MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons